Abbott Laboratories
105.23USD
-0.2900 (-0.27%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11,164 | 11,459 | 11,369 | 11,142 | 10,358 | 10,974 | 10,635 | 10,377 |
| Cost of Revenue | 4,890 | 4,922 | 5,075 | 4,854 | 4,468 | 4,942 | 4,698 | 4,603 |
| Gross Profit | 6,274 | 6,537 | 6,294 | 6,288 | 5,890 | 6,032 | 5,937 | 5,774 |
| Operating Income | 1,345 | 2,251 | 2,057 | 2,052 | 1,693 | 1,911 | 1,859 | 1,669 |
| Net Income | 1,077 | 1,776 | 1,644 | 1,779 | 1,325 | 9,229 | 1,646 | 1,302 |
| EPS (Diluted) | $0.61 | $1.02 | $0.94 | $1.01 | $0.76 | $5.26 | $0.94 | $0.74 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)